Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.52 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.52 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.52 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.52 |
| ▸ | BCHE | P06276 | 1/20 | 0.45 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.44 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7599536 | 0.91 | PDE4A (0.45) | PDE4APDE4BPDE4CPDE4DMRGPRX4 | |
| SCHEMBL8465351 | 0.90 | PDE4D (0.47) | PDE4APDE4BPDE4CPDE4DMRGPRX4 | |
| SCHEMBL7517816 | 0.88 | ADCYAP1R1 (0.46) | PDE4APDE4BPDE4CPDE4DMRGPRX4 | |
| SCHEMBL7044465 | 0.87 | PDE4A (0.47) | PDE4APDE4BPDE4CPDE4DKCNA3 | |
| SCHEMBL7519964 | 0.84 | KRAS (0.47) | PTPN1LMNAHPGD | |
| SCHEMBL6877711 | 0.82 | PTPN1 (0.48) | PDE4APDE4BPDE4CPDE4DPTPN1 | |
| SCHEMBL7626410 | 0.81 | KMT2A (0.43) | LMNAHPGD | |
| SCHEMBL7597538 | 0.81 | KRAS (0.46) | PDE4APDE4BPDE4CPDE4DATM | |
| SCHEMBL7602839 | 0.80 | ALDH1A1 (0.42) | LMNAHPGDATM | |
| SCHEMBL7521268 | 0.80 | ATM (0.43) | PDE4APDE4BPDE4CPDE4DMRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6734202-B2 | SYNERGISTIC MIXTURE OF BENZOPHENONE(S) OF GIVEN FORMULA, AND FUNGICIDAL STROBILURINE DERIVATIVE | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-11 | — | — | US | claimed |
| US-6521628-B1 | Such as 5-bromo-2',6-dimethyl-2,4',5',6'-tetramethoxybenzo-phenone and 5-chloro-6-(2,4,6-trifluorophenyl)-7-(1,1,1 -(trifluoro)propylamino)(1,2,4)triazolo(1,5-a)pyrimidine | BASF AKTIENGESELLSCHAFT (DE) | 2003-02-18 | — | — | US | claimed |
| US-6498194-B2 | SYNERGISTIC MIXTURE OF BENZOPHENONE(S) OF GIVEN FORMULA, AND FUNGICIDAL ACTIVE INGREDIENTS SELECTED FROM CATEGORIES INCLUDING ERGOSTEROL OR MELANIN BIOSYTHESIS INHIBITORS, A STROBILURINE DERIVATIVE, AND AZOLOPYRIMIDINES | BASF AKTIENGSELLSCHAFT (DE) | 2002-12-24 | — | — | US | claimed |
| US-20020099063-A1 | Fungicidal mixtures | AMERICAN CYANAMID COMPANY (US) | 2002-07-25 | — | — | US | claimed |
| US-20020099062-A1 | Fungicidal mixtures | AMERICAN CYANAMID COMPANY (US) | 2002-07-25 | — | — | US | claimed |
| US-20020065313-A1 | Fungicidal mixtures | BASF AKTIENGESELLSCHAFT (DE) | 2002-05-30 | — | — | US | claimed |
| US-6346535-B1 | Fungicidal mixtures | AMERICAN CYANAMID COMPANY | 2002-02-12 | — | — | US | claimed |
| EP-1023834-A1 | Fungicidal mixtures | American Cyanamid Company (US) | 2000-08-02 | — | — | EP | claimed |
| EP-1023832-B1 | Aqueous suspension concentrate | BASF AG (DE) | 2004-11-17 | — | — | EP | disclosed |
| US-6613806-B1 | Adding adjuvants which reduce surface tension, selected from alkoxylated alcohols, amines or acids; water-immiscible polar aprotic solvents; alkyl polyglycosides, polyvinylpyrrolidones, alkenylsuccinic acids, sulfosuccinates, perfluoro compounds | BASF CORPORATION | 2003-09-02 | — | — | US | disclosed |
| US-6596775-B2 | Fungicides | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-22 | — | — | US | disclosed |
| US-20030060514-A1 | Aqueous suspension concentrate | BASF AKTIENGESELLSCHAFT (DE) | 2003-03-27 | — | — | US | disclosed |
| US-20020155518-A1 | Method of detecting compounds that control fungal diseases via effects on sporulation | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-24 | — | — | US | disclosed |
| US-6383984-B1 | AQUEOUS, CONCENTRATED SUSPENSION FOR CROP PROTECTION ACTIVE COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2002-05-07 | — | — | US | disclosed |
| US-20020028778-A1 | Enhancement of the efficacy of benzoylbenzenes | AVEN MICHAEL (DE) | 2002-03-07 | — | — | US | disclosed |
| EP-1023834-A1 | Fungicidal mixtures | American Cyanamid Company (US) | 2000-08-02 | — | — | EP | disclosed |
| EP-1023835-A1 | Enhancement of the efficacy of benzoylbenzenes | American Cyanamid Company (US) | 2000-08-02 | — | — | EP | disclosed |
| EP-1023832-A1 | Aqueous suspension concentrate | American Cyanamid Company (US) | 2000-08-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020099063-A1 | Fungicidal mixtures | DDT, CYP2D6, CYP1B1 | PDE4A 2745/4885PDE4B 2112/4885PDE4C 2977/4885 |
| US-20020028778-A1 | Enhancement of the efficacy of benzoylbenzenes | GABRB1, GABBR1, FOXM1 | PDE4A 4782/4885PDE4B 4552/4885PDE4C 4662/4885 |
| US-20020065313-A1 | Fungicidal mixtures | CYP1B1, CYP51A1, CYP3A7 | PDE4A 3272/4885PDE4B 2713/4885PDE4C 3616/4885 |
| US-20020099062-A1 | Fungicidal mixtures | DDT, CYP2D6, CYP1B1 | PDE4A 2745/4885PDE4B 2112/4885PDE4C 2977/4885 |
| US-20030060514-A1 | Aqueous suspension concentrate | SGMS2, SGMS1, SCD | PDE4A 2815/4885PDE4B 2159/4885PDE4C 2292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.